ARTHRITIS, PSORIATIC

This study is checking the long-term safety of guselkumab in children who already benefited from it in previous studies. It includes 196 children with Crohn's disease, ulcerative colitis, or juvenile psoriatic arthritis. The main goal is to see if the drug remains safe when used …

This study is testing whether an experimental drug called JNJ-88545223 can help control the symptoms of active psoriatic arthritis. About 240 adults with this condition will receive either the drug or a placebo for 16 weeks to see if it reduces joint swelling, tenderness, and ski…

This study is testing whether a new medication called sonelokimab can help control psoriatic arthritis in adults whose current treatments aren't working well enough. It will compare two doses of sonelokimab against a placebo (inactive treatment) and an existing medication in abou…

This study is testing whether an experimental drug called JNJ-77242113 (icotrokinra) can reduce joint pain, swelling, and skin symptoms in people with active psoriatic arthritis who have already tried at least one other biologic medication. About 750 participants will be randomly…

This study is checking how well the medication guselkumab works for people with active psoriatic arthritis in everyday medical practice. It will follow 200 participants for up to a year, using special ultrasound imaging to measure inflammation in their joints and tendons. The mai…

This study is testing how safe and effective the drug guselkumab is for Indian patients with psoriatic arthritis, a painful autoimmune condition that affects the joints and skin. It is for people whose symptoms have not improved enough with standard medications. Researchers will …

This study is testing whether an injectable medication called guselkumab can reduce back pain and spinal inflammation in people with active psoriatic arthritis. About 405 participants who have not tried biologic drugs will receive either the medication or a placebo for 24 weeks, …

This study aims to understand how different compounds from the cannabis plant affect immune cells in a lab setting. Researchers will collect blood from 100 patients with chronic inflammatory diseases like rheumatoid arthritis and lupus. They will test various cannabis extracts on…